# The Effect of Brimonidine

> **NCT03959176** · PHASE4 · COMPLETED · sponsor: **Wake Forest University Health Sciences** · enrollment: 13 (actual)

## Conditions studied

- Intraocular Pressure

## Interventions

- **DRUG:** Brimonidine
- **DRUG:** Tropicamide
- **DRUG:** Phenylephrine Ophthalmic Product

## Key facts

- **NCT ID:** NCT03959176
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-20
- **Primary completion:** 2019-07-20
- **Final completion:** 2019-07-20
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2024-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03959176

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03959176, "The Effect of Brimonidine". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03959176. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*